Jul 1, 2026 09:01AM

Jul 1, 2026 09:00AM

Jun 22, 2026 09:15AM

Jun 22, 2026 09:15AM

Apr 28, 2026 09:02AM

Apr 28, 2026 09:01AM

Jan 13, 2026 09:15AM Creative Medical reports positive interim data for chronic back pain therapy

Jan 13, 2026 09:15AM

Dec 17, 2025 09:15AM

Dec 17, 2025 09:15AM

Dec 2, 2025 09:15AM

Dec 2, 2025 09:15AM

Oct 27, 2025 08:15AM

Oct 27, 2025 08:15AM Creative Medical Technology Holdings Issues Letter to Shareholders

Aug 13, 2025 09:01AM

Aug 13, 2025 09:01AM

Mar 20, 2025 07:50AM

Mar 20, 2025 07:50AM

Feb 20, 2025 08:00AM

Feb 14, 2025 07:00AM

Feb 11, 2025 09:25AM Creative Medical Technology (CELZ) Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program

Feb 11, 2025 09:25AM

Nov 13, 2024 09:01AM

Nov 13, 2024 09:00AM

Jul 24, 2024 09:03AM

Jul 24, 2024 09:00AM

Jul 10, 2024 08:32AM

Jul 10, 2024 08:30AM Creative Medical Technology Holdings Provides Corporate Update

Jun 24, 2024 08:30AM

Mar 27, 2024 09:00AM

Mar 7, 2024 09:15AM

Mar 7, 2024 09:15AM

Mar 6, 2024 07:00AM

Mar 6, 2024 07:00AM

Dec 20, 2023 09:38AM Creative Medical Technology (CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem For Addressing Chronic Lower Back Pain

Dec 20, 2023 09:33AM

Nov 15, 2023 08:00AM

Oct 10, 2023 08:00AM

Sep 19, 2023 08:01AM

Sep 19, 2023 08:00AM

Aug 24, 2023 10:45AM

Jul 13, 2023 09:00AM Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update

Jun 12, 2023 08:00AM

Jun 12, 2023 08:00AM

Apr 12, 2023 08:01AM

Apr 12, 2023 08:00AM

Apr 4, 2023 08:00AM

Mar 23, 2023 08:00AM

Mar 7, 2023 08:07AM Creative Medical Technology (CELZ) Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201

Mar 7, 2023 08:00AM

325,079 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All